Review
Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry
Empleo de nuevas técnicas complementarias a la IHQ para diagnóstico de lesiones melanocíticas, con énfasis en HGC, FISH y espectrometría de masas
P. Nagarajan, M.T. Tetzlaff, J.L. Curry, V.G. Prieto
Autor para correspondencia
Department of Pathology, Unit 85, University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States
Leído
10061
Vecesse ha leído el artículo
3163
Total PDF
6898
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S0001731016301545" "issn" => "00017310" "doi" => "10.1016/j.ad.2016.05.005" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "1437" "copyright" => "AEDV" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2017;108:17-30" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1067 "formatos" => array:3 [ "EPUB" => 60 "HTML" => 497 "PDF" => 510 ] ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S1578219016303328" "issn" => "15782190" "doi" => "10.1016/j.adengl.2016.05.030" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "1437" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2017;108:17-30" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1162 "formatos" => array:3 [ "EPUB" => 42 "HTML" => 827 "PDF" => 293 ] ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:3 [ 0 => "en" 1 => "en" 2 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "17" "paginaFinal" => "30" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Empleo de nuevas técnicas complementarias a la IHQ para diagnóstico de lesiones melanocíticas, con énfasis en HGC, FISH y espectrometría de masas" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0045" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 566 "Ancho" => 1333 "Tamanyo" => 197735 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "P. Nagarajan, M.T. Tetzlaff, J.L. Curry, V.G. Prieto" "autores" => array:4 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Nagarajan" ] 1 => array:2 [ "nombre" => "M.T." "apellidos" => "Tetzlaff" ] 2 => array:2 [ "nombre" => "J.L." "apellidos" => "Curry" ] 3 => array:2 [ "nombre" => "V.G." "apellidos" => "Prieto" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0045"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0001731016301545" "doi" => "10.1016/j.ad.2016.05.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016301545?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219016303328?idApp=UINPBA000044" "url" => "/15782190/0000010800000001/v1_201612300037/S1578219016303328/v1_201612300037/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0001731016302848" "issn" => "00017310" "doi" => "10.1016/j.ad.2016.07.016" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "1485" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2017;108:31-41" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1057 "formatos" => array:3 [ "EPUB" => 3 "HTML" => 794 "PDF" => 260 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">DERMATOLOGÍA PRÁCTICA</span>" "titulo" => "Precáncer cutáneo" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "31" "paginaFinal" => "41" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Precancerous Skin Lesions" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 660 "Ancho" => 989 "Tamanyo" => 93488 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Examen dermatoscópico de una queratosis actínica. Típica imagen «en fresa».</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Ferrándiz, J. Malvehy, C. Guillén, C. Ferrándiz-Pulido, M. Fernández-Figueras" "autores" => array:5 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Ferrándiz" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Malvehy" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Guillén" ] 3 => array:2 [ "nombre" => "C." "apellidos" => "Ferrándiz-Pulido" ] 4 => array:2 [ "nombre" => "M." "apellidos" => "Fernández-Figueras" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219016303006" "doi" => "10.1016/j.adengl.2016.11.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219016303006?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016302848?idApp=UINPBA000044" "url" => "/00017310/0000010800000001/v1_201612270122/S0001731016302848/v1_201612270122/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0001731016302319" "issn" => "00017310" "doi" => "10.1016/j.ad.2016.05.019" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "1460" "copyright" => "AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2017;108:6-16" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1855 "formatos" => array:3 [ "EPUB" => 59 "HTML" => 1118 "PDF" => 678 ] ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:3 [ 0 => "en" 1 => "en" 2 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "6" "paginaFinal" => "16" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Efectos cutáneos adversos de los nuevos tratamientos para melanoma: Clasificación y Tratamiento" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0020" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 1085 "Ancho" => 995 "Tamanyo" => 127831 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S.J.E. Hwang, R. Anforth, G. Carlos, P. Fernandez-Peñas" "autores" => array:4 [ 0 => array:2 [ "nombre" => "S.J.E." "apellidos" => "Hwang" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "Anforth" ] 2 => array:2 [ "nombre" => "G." "apellidos" => "Carlos" ] 3 => array:2 [ "nombre" => "P." "apellidos" => "Fernandez-Peñas" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0020"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219016303316" "doi" => "10.1016/j.adengl.2016.05.029" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219016303316?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016302319?idApp=UINPBA000044" "url" => "/00017310/0000010800000001/v1_201612270122/S0001731016302319/v1_201612270122/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "17" "paginaFinal" => "30" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "P. Nagarajan, M.T. Tetzlaff, J.L. Curry, V.G. Prieto" "autores" => array:4 [ 0 => array:2 [ "nombre" => "P." "apellidos" => "Nagarajan" ] 1 => array:2 [ "nombre" => "M.T." "apellidos" => "Tetzlaff" ] 2 => array:2 [ "nombre" => "J.L." "apellidos" => "Curry" ] 3 => array:4 [ "nombre" => "V.G." "apellidos" => "Prieto" "email" => array:1 [ 0 => "Vprieto@mdanderson.org" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Pathology, Unit 85, University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Empleo de nuevas técnicas complementarias a la IHQ para diagnóstico de lesiones melanocíticas, con énfasis en HGC, FISH y espectrometría de masas" ] ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0045" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 566 "Ancho" => 1333 "Tamanyo" => 197735 ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Accurate diagnosis of melanoma is the most important prerequisite for optimal clinical management. Examination of hematoxylin and eosin (H&E) stained sections using conventional microscopy remains the gold standard for diagnosis of melanocytic lesions and as such most of the criteria used in the American Joint Committee on Cancer (AJCC)/College of American Pathologists (CAP) recommendations for reporting specimens with melanoma are based on routine examination of histologic slides.<a class="elsevierStyleCrossRef" href="#bib0810"><span class="elsevierStyleSup">1</span></a> However, when lesions exhibit architectural and cytologic features that overlap both melanocytic nevi and melanomas, histologic examination alone may be insufficient for diagnosis. Being one of the ultimate histologic mimickers, melanoma may present in a range of histologic variants with spindle cell, desmoplastic, clear cell, balloon cell, signet ring cell, small cell, plasmacytoid and rhabdoid phenotypes.<a class="elsevierStyleCrossRefs" href="#bib0815"><span class="elsevierStyleSup">2–4</span></a> Rarely, even establishing melanocytic lineage of a tumor may become a challenging task, especially when the tumor cells are poorly differentiated and resemble multiple other tumors such as carcinoma, lymphoma, neuroendocrine carcinoma, angiosarcoma, fibrohistiocytic, and small round blue cell tumors.<a class="elsevierStyleCrossRef" href="#bib0830"><span class="elsevierStyleSup">5</span></a> The objective of this article is to review the various ancillary tests that are available to pathologists that assist in the diagnosis of melanocytic lesions as well as their possible application to determine prognosis and therapy.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Immunohistochemistry</span><p id="par0010" class="elsevierStylePara elsevierViewall">Immunohistochemistry (IHC) is arguably the most commonly employed ancillary test in pathology. This staining technique is used to detect the presence or absence of an antigen usually a protein.<a class="elsevierStyleCrossRefs" href="#bib0835"><span class="elsevierStyleSup">6,7</span></a> Introduced in the early 1940s, the current IHC protocols utilize specific antibodies tagged with a visible label or chromogenic agent against the target molecule.<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">8</span></a> The presence of the antigen is revealed by serial amplification of the initial signal, thus enabling visualization of the protein and its distribution within the various cellular and extracellular components of the tissue as well as within the subcellular compartments.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Diaminobenzidine (DAB) is the most commonly used chromogen, which produces a brown precipitate. However, in heavily pigmented lesions, distinguishing the immunoreaction from melanin pigment can be challenging; therefore, other chromogens may be used including fast red or 3-amino-9-ethylcarbazole (AEC) or Texas red. An alternate approach would be to use a counterstain other than hematoxylin such as azure B or Giemsa to convert the brown pigment of melanin to green.<a class="elsevierStyleCrossRef" href="#bib0850"><span class="elsevierStyleSup">9</span></a> Such method allows distinction between the brown DAB and the now green-colored melanin. Bleaching of melanin using potassium permanganate solution may affect the antigenicity of some epitopes and thus, affect immunodetection of certain markers.<a class="elsevierStyleCrossRef" href="#bib0850"><span class="elsevierStyleSup">9</span></a> However, bleaching using hydrogen peroxide may be a better alternative.<a class="elsevierStyleCrossRef" href="#bib0855"><span class="elsevierStyleSup">10</span></a> But we recommend avoiding such techniques.<a class="elsevierStyleCrossRef" href="#bib0860"><span class="elsevierStyleSup">11</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Though many of the common melanocyte specific markers are useful in the diagnosis of melanocytic lesions and primary melanomas,<a class="elsevierStyleCrossRefs" href="#bib0860"><span class="elsevierStyleSup">11,12</span></a> their expression may be lost focally or diffusely as the disease progresses, particularly in metastatic lesions. In addition, there might be acquired variable and aberrant expression of non-melanocytic markers such as cytokeratins, and neuroendocrine markers.<a class="elsevierStyleCrossRefs" href="#bib0870"><span class="elsevierStyleSup">13–15</span></a> This altered immunohistochemical profile may be accompanied by unusual tissue morphology as well. Therefore, one must exercise caution when examining a poorly differentiated neoplasm in a patient with prior history of melanoma. The following section will summarize commonly used diagnostic and prognostic markers of melanoma, not including the less commonly utilized markers such as PNL2, KBA.62, SM5-1, MC1R, NKI/C3, CSPG4 and CD146.<a class="elsevierStyleCrossRefs" href="#bib0830"><span class="elsevierStyleSup">5,16,17</span></a></p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Markers of melanocytic differentiation</span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">S100B</span><p id="par0025" class="elsevierStylePara elsevierViewall">Since its expression in melanoma cell lines was documented 35 years ago, S100B, also referred to as just ‘S100’, is the most analyzed marker of melanocytic differentiation.<a class="elsevierStyleCrossRefs" href="#bib0895"><span class="elsevierStyleSup">18–21</span></a> It is a member of the S100 family of calcium binding heteromeric proteins that is expressed in a variety of tissues including melanocytes.<a class="elsevierStyleCrossRef" href="#bib0915"><span class="elsevierStyleSup">22</span></a> In addition to being expressed intracellularly, and thus, being detectable by IHC, S100 is also secreted in the serum.<a class="elsevierStyleCrossRef" href="#bib0920"><span class="elsevierStyleSup">23</span></a> The sensitivity of S100 in melanomas is very high in formalin-fixed tissues and thus, more than 90% of all primary melanomas, including desmoplastic variants, express S100 protein.<a class="elsevierStyleCrossRefs" href="#bib0925"><span class="elsevierStyleSup">24,25</span></a> However, its expression may be lost in metastases as well as in some spindle cell/desmoplastic melanomas.<a class="elsevierStyleCrossRefs" href="#bib0935"><span class="elsevierStyleSup">26,27</span></a> Also, since the specificity of S100 is not high, it is advisable to use it in conjunction with other melanocytic markers. Regarding tissue processing, S100 protein is soluble in organic solvents such as acetone and alcohol. Therefore, frozen tissue sections and cytology preparations utilizing alcohol based fixatives are likely to yield false negative results and are not recommended for S100 IHC.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">HMB45</span><p id="par0030" class="elsevierStylePara elsevierViewall">Human Melanoma Black-45 (HMB-45) is a mouse monoclonal antibody that recognizes gp100 or Pmel17, a premelanosome protein,<a class="elsevierStyleCrossRefs" href="#bib0945"><span class="elsevierStyleSup">28,29</span></a> which makes HMB45 very specific marker for melanocytic proliferations. Expression of HMB45 is directly proportional to melanin synthesizing capacity of the cells; therefore, melanocytes of blue nevi and some Spitz nevi exhibit uniform staining throughout the lesion,<a class="elsevierStyleCrossRef" href="#bib0955"><span class="elsevierStyleSup">30</span></a> whereas the maturing dermal melanocytes of banal compound and intradermal nevi progressively lose their HMB45 expression.<a class="elsevierStyleCrossRefs" href="#bib0865"><span class="elsevierStyleSup">12,31</span></a> Most of the primary epithelioid melanomas, on the other hand are typically characterized by patchy expression of HMB45, while a majority of the desmoplastic melanomas tend to be negative for HMB45.<a class="elsevierStyleCrossRefs" href="#bib0965"><span class="elsevierStyleSup">32,33</span></a> As such, diffuse expression through the lesion or limited to the intra- and periepithelial melanocytes is usually associated with a diagnosis of nevus while patchy expression is more likely to be seen in melanomas.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">MART1</span><p id="par0035" class="elsevierStylePara elsevierViewall">Melanoma antigen recognized by T cells-1 (MART1/Melan-A) was identified as one of proteins recognized by tumor-infiltrating lymphocytes.<a class="elsevierStyleCrossRef" href="#bib0975"><span class="elsevierStyleSup">34</span></a> MART1 interacts with gp100 and plays an important role in trafficking of gp100 to premelanosomes.<a class="elsevierStyleCrossRef" href="#bib0980"><span class="elsevierStyleSup">35</span></a> It is one of the most widely used markers of melanocytic differentiation, recognized by 2 clones of antibodies: M2-7C10 and A103.<a class="elsevierStyleCrossRefs" href="#bib0985"><span class="elsevierStyleSup">36,37</span></a> MART1 is expressed by almost all benign melanocytic lesions as well as by the majority of epithelioid melanomas.<a class="elsevierStyleCrossRefs" href="#bib0995"><span class="elsevierStyleSup">38,39</span></a> However, desmoplastic melanomas are predominantly negative for MART1.<a class="elsevierStyleCrossRef" href="#bib0995"><span class="elsevierStyleSup">38</span></a> One of the drawbacks consistently seen with MART1 is the over-estimation of junctional melanocytes in chronically sun-damaged skin.<a class="elsevierStyleCrossRefs" href="#bib1005"><span class="elsevierStyleSup">40–42</span></a> This is due to localization of MART1 to melanosomes and the plasma membrane, in addition to the Golgi apparatus and other organelles and thus, to the dendritic processes of the melanocytes.<a class="elsevierStyleCrossRef" href="#bib1020"><span class="elsevierStyleSup">43</span></a> Therefore, extreme caution must be employed while interpreting intraepidermal pigmented lesions studied solely with anti-MART1.<a class="elsevierStyleCrossRef" href="#bib1015"><span class="elsevierStyleSup">42</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Tyrosinase</span><p id="par0040" class="elsevierStylePara elsevierViewall">Tyrosinase is a copper-containing metalloenzyme that catalyzes three reactions in the melanin synthetic pathway, including hydroxylation of tyrosine.<a class="elsevierStyleCrossRef" href="#bib1025"><span class="elsevierStyleSup">44</span></a><span class="elsevierStyleItalic">Tyrosinase</span> gene encodes for peptides recognized by cytolytic T-cells in melanoma patients.<a class="elsevierStyleCrossRef" href="#bib1030"><span class="elsevierStyleSup">45</span></a> Tyrosinase is expressed in almost all epithelioid melanocytic lesions in a finely granular pattern within the cytoplasm. Though most melanocytic nevi express tyrosinase, the intensity of staining may decrease gradually as the melanocytes descend into the deep dermis.<a class="elsevierStyleCrossRef" href="#bib1035"><span class="elsevierStyleSup">46</span></a> It is expressed in most epithelioid melanomas, where the pattern can be patchy, but the labeling is frequently weak, focal or absent in melanomas with spindled melanocytes and in metastatic melanomas.<a class="elsevierStyleCrossRefs" href="#bib1040"><span class="elsevierStyleSup">47,48</span></a> In general, tyrosinase is comparable to HMB45 in terms of expression and usefulness in the diagnosis of melanocytic lesions.<a class="elsevierStyleCrossRef" href="#bib0865"><span class="elsevierStyleSup">12</span></a></p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">MITF</span><p id="par0045" class="elsevierStylePara elsevierViewall">Microphthalmia-associated transcription factor (MITF) is a dimeric transcription factor that plays a seminal role in melanocyte development, proliferation, function and survival.<a class="elsevierStyleCrossRefs" href="#bib1050"><span class="elsevierStyleSup">49–51</span></a> Though expressed in several other cells such as macrophages, fibroblasts, smooth muscle cells, Schwann cells and mast cells, the nuclear localization of this protein offers a major advantage in the detection of melanocytes<a class="elsevierStyleCrossRef" href="#bib1065"><span class="elsevierStyleSup">52</span></a>. This is particularly useful when the lesion is densely pigmented. Melanocytic nevi, epithelioid melanomas as well as metastatic melanomas with epithelioid morphology express MITF, while spindled and desmoplastic melanomas are typically negative (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A).<a class="elsevierStyleCrossRefs" href="#bib1070"><span class="elsevierStyleSup">53–55</span></a> One of principal uses of MITF is the accurate enumeration of melanocytes in intraepidermal melanocytic proliferations to distinguish between pigmented actinic keratosis from lentigo maligna (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B).<a class="elsevierStyleCrossRefs" href="#bib1085"><span class="elsevierStyleSup">56,57</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">SOX10</span><p id="par0050" class="elsevierStylePara elsevierViewall">Sex determinant region Y (SRY) related HMG-box gene 10 (SOX10), is a transcription factor that binds to and transactivates <span class="elsevierStyleItalic">MITF</span> gene promoter and regulates the expression of tyrosinase-related protein-1 among others and plays a critical role in melanocyte growth and function.<a class="elsevierStyleCrossRefs" href="#bib1095"><span class="elsevierStyleSup">58,59</span></a> SOX10 is a nuclear marker that can be expressed in Schwann cells, eccrine epithelium, myoepithelial cells and glial cells.<a class="elsevierStyleCrossRefs" href="#bib1105"><span class="elsevierStyleSup">60,61</span></a> Similar to MITF, SOX10 is a useful marker for the distinction of pigmented actinic keratosis from melanoma in situ (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>A).<a class="elsevierStyleCrossRef" href="#bib1090"><span class="elsevierStyleSup">57</span></a>. It is also more sensitive than MITF in that almost all spindle cell melanomas and most desmoplastic melanomas express SOX10 (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>B)<a class="elsevierStyleCrossRefs" href="#bib1105"><span class="elsevierStyleSup">60,62,63</span></a>.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">p75NGFR</span><p id="par0055" class="elsevierStylePara elsevierViewall">Nerve growth factor receptor (molecular weight: 75<span class="elsevierStyleHsp" style=""></span>kDa), also known as neurotropin receptor and CD271 belongs to the tumor necrosis factor receptor superfamily and is widely expressed in the skin. Transit amplifying keratinocytes of basal layer, follicular outer root sheaths, myoepithelial cells, fibroblasts and nerve fibers express NGFR.<a class="elsevierStyleCrossRefs" href="#bib1125"><span class="elsevierStyleSup">64,65</span></a> It is not expressed in epithelioid type-A melanocytes; but is induced during neurotization and as such is expressed in melanocytes with spindled morphology (type-C). NGFR has a higher sensitivity for detection of spindle cell and desmoplastic melanomas and has been touted to be a better marker than S100 for spindle cell melanomas.<a class="elsevierStyleCrossRef" href="#bib0940"><span class="elsevierStyleSup">27</span></a> In addition, other spindle cells tumors of sun-damaged skin are frequently negative for NGFR.<a class="elsevierStyleCrossRefs" href="#bib1135"><span class="elsevierStyleSup">66,67</span></a> However, caution must be exercised while using NGFR as a sole marker of desmoplastic or spindle cell melanoma, since it can be expressed in dermatofibrosarcoma protuberans and scars.<a class="elsevierStyleCrossRefs" href="#bib1145"><span class="elsevierStyleSup">68,69</span></a></p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Melanocytic marker cocktails</span><p id="par0060" class="elsevierStylePara elsevierViewall">Sometimes, a mixture of 2 or more monoclonal antibodies against melanocytic markers is used in immunohistochemistry.<a class="elsevierStyleCrossRefs" href="#bib1155"><span class="elsevierStyleSup">70,71</span></a> Though many of these cocktails are generated and validated in individual laboratories, some are also commercially available.<a class="elsevierStyleCrossRef" href="#bib0885"><span class="elsevierStyleSup">16</span></a> The main advantage of this is the increased sensitivity for detection of melanocytes. For instance, combination of HMB45 and anti-tyrosinase can be used to determine the number and growth pattern of intraepidermal melanocytes and for detecting the presence of a dermal component as well (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>). The main application of such cocktails is in establishing a melanocytic origin in a given neoplasm and in the detection of microscopic metastases in sentinel lymph nodes.</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Prognostic markers of melanoma</span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Ki67</span><p id="par0065" class="elsevierStylePara elsevierViewall">Marker of proliferation Ki67 is a nuclear non-histone protein that is expressed in actively proliferating cells (not in G0 phase).<a class="elsevierStyleCrossRef" href="#bib1165"><span class="elsevierStyleSup">72</span></a> The proliferative activity, as indicated by the percentage of lesional cells expressing Ki67 could be extrapolated to determine the biologic behavior of the melanocytic lesion. In general, fewer than 5% (usually 1%) of melanocytes comprising most benign lesions expressed Ki67,<a class="elsevierStyleCrossRefs" href="#bib0865"><span class="elsevierStyleSup">12,73,74</span></a> with a decreasing gradient toward the deeper aspect, reflecting maturation of melanocytes with progressive dermal descent.<a class="elsevierStyleCrossRef" href="#bib1180"><span class="elsevierStyleSup">75</span></a> In melanomas, the Ki67 proliferation index is higher, ranging from 5% to 50%, with mitotic figurees distributed throughout the lesion.<a class="elsevierStyleCrossRef" href="#bib1180"><span class="elsevierStyleSup">75</span></a> In some cases, foci of increased proliferation may be seen. Increased Ki67 proliferation rate has been correlated with recurrence and metastasis, particular in thick melanomas.<a class="elsevierStyleCrossRefs" href="#bib1185"><span class="elsevierStyleSup">76–78</span></a> To help distinguish between proliferating melanocytes and other cells at our institution, the growth fraction is determined by adding a cytoplasmic melanocytic marker such as MART1/Melan-A/tyrosinase to anti-Ki67 (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>A). This combination is particularly useful in lesions with a brisk inflammatory infiltrate. In addition, Ki67 positivity of intraepidermal melanocytes is seen more commonly in in situ melanomas, compared to nevi.<a class="elsevierStyleCrossRef" href="#bib1200"><span class="elsevierStyleSup">79</span></a></p><elsevierMultimedia ident="fig0020"></elsevierMultimedia></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">pHH3</span><p id="par0070" class="elsevierStylePara elsevierViewall">Identification of mitotic figures is an important staging parameter in thin melanomas (Breslow thickness<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>1.0<span class="elsevierStyleHsp" style=""></span>mm).<a class="elsevierStyleCrossRef" href="#bib1205"><span class="elsevierStyleSup">80</span></a> Phosphorylation of histone H3 begins in the late G2 phase of cell cycle. Phosphohistone H3 (pHH3) can be detected throughout the entire M-phase and thus, is a marker of cells undergoing mitosis.<a class="elsevierStyleCrossRefs" href="#bib1210"><span class="elsevierStyleSup">81–83</span></a> pHH3 expression in dermal melanocytes has been correlated with outcomes in melanoma.<a class="elsevierStyleCrossRefs" href="#bib1225"><span class="elsevierStyleSup">84–87</span></a> While manually identifiable mitotic figures do not include cells in prophase, pHH3 detects these cells as well. The AJCC-TNM (2009) staging system is based on mitotic figures detected on routine, H&E-stained slides, and thus immunedetection of pHH3 should not be used in routine examination of primary melanomas. Anti-pHH3 antibody may also be combined with a cytoplasmic melanocytic marker such as MART1 to enhance detection of actively dividing melanocytes (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>B).<a class="elsevierStyleCrossRefs" href="#bib1225"><span class="elsevierStyleSup">84,88</span></a> At our institution we use such a combination of anti-MART1 and anti-pHH3 in cases where we identify cells undergoing mitosis but we are not certain if they correspond to a melanocyte or to other dermal cells (e.g., endothelial cells, lymphocytes, macrophages).</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">D2-40</span><p id="par0075" class="elsevierStylePara elsevierViewall">D2-40 is a monoclonal antibody that recognizes podoplanin, a transmembrane mucoprotein that is selectively expressed in lymphatic endothelium.<a class="elsevierStyleCrossRefs" href="#bib1250"><span class="elsevierStyleSup">89,90</span></a> Presence of lymphovascular space invasion (LVI) by melanoma has been correlated with metastases to sentinel and regional lymph nodes, and decreased disease-free and overall survival.<a class="elsevierStyleCrossRefs" href="#bib1260"><span class="elsevierStyleSup">91–93</span></a> Detection of LVI by examination of H&E stained sections alone may be difficult since filling up of small vessels with tumor cells may lead to flattening of endothelium, while retraction artifacts and dyshesive properties of the tumor cells may mimic a vascular space.<a class="elsevierStyleCrossRef" href="#bib1275"><span class="elsevierStyleSup">94</span></a> Therefore, the use of lymphatic and vascular endothelial markers has become a common practice, particularly in thick melanomas. Dual immunostaining using S100/D2-40 cocktail did not correlate with sentinel lymph node status.<a class="elsevierStyleCrossRef" href="#bib1280"><span class="elsevierStyleSup">95</span></a> However, a recent study from our group revealed that detection rates of LVI were increased by using MITF/D2-40 cocktail with positive correlation with sentinel lymph node metastasis (<a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a>C).<a class="elsevierStyleCrossRef" href="#bib1285"><span class="elsevierStyleSup">96</span></a></p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">BRAFV600E</span><p id="par0080" class="elsevierStylePara elsevierViewall">Somatic missense mutations in <span class="elsevierStyleItalic">BRAF</span>, a cytoplasmic serine/threonine kinase are common in cutaneous melanomas (50–60%).<a class="elsevierStyleCrossRef" href="#bib1290"><span class="elsevierStyleSup">97</span></a> A single nucleotide mutation 1799 T<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>A constitutes more than 90% of these mutations, resulting in substitution of glutamic acid for valine (BRAF V600E). With the advent of BRAF inhibitors, detection of this mutation has acquired a paramount importance in management of patients with metastatic melanoma.<a class="elsevierStyleCrossRefs" href="#bib1295"><span class="elsevierStyleSup">98,99</span></a> Though the gold standard is molecular testing, immunohistochemical studies using anti-BRAFV600E antibody (clone VE1) have demonstrated high concordance with the results of molecular analysis.<a class="elsevierStyleCrossRefs" href="#bib1305"><span class="elsevierStyleSup">100–103</span></a> The staining is usually diffuse and cytoplasmic (<a class="elsevierStyleCrossRef" href="#fig0025">Fig. 5</a>); but, focal staining is also observed in several cases,<a class="elsevierStyleCrossRef" href="#bib1220"><span class="elsevierStyleSup">83</span></a> which could be attributed in part to technical issues.<a class="elsevierStyleCrossRef" href="#bib1325"><span class="elsevierStyleSup">104</span></a> Nevertheless, other studies have demonstrated that the heterogeneous BRAF V600E staining could indeed be a reflection of the polyclonal nature of melanoma.<a class="elsevierStyleCrossRef" href="#bib1330"><span class="elsevierStyleSup">105</span></a> Caution must be exercised when analyzing the slides, especially in densely pigmented lesions, where the cytoplasmic melanin pigment may mimic positive staining. In such cases, counterstaining with Giemsa is warranted in order to avoid a false positive reading.<a class="elsevierStyleCrossRef" href="#bib1335"><span class="elsevierStyleSup">106</span></a> Recent reports have demonstrated that the immunostain might be too sensitive in some cases,<a class="elsevierStyleCrossRef" href="#bib1340"><span class="elsevierStyleSup">107</span></a> so more studies may be needed to determine the clinical application of immunohistochemical detection of BRAF V600E.</p><elsevierMultimedia ident="fig0025"></elsevierMultimedia></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">BAP1</span><p id="par0085" class="elsevierStylePara elsevierViewall">Breast cancer type 1 susceptibility protein (BRCA1) associated protein-1 (BAP1), is a ubiquitin carboxy-terminal hydrolase that functions as a tumor suppressor.<a class="elsevierStyleCrossRefs" href="#bib1345"><span class="elsevierStyleSup">108,109</span></a> Individuals with heterozygous germline <span class="elsevierStyleItalic">BAP1</span> mutations are at high-risk for developing a variety of tumors, including asbestos-associated mesothelioma, lung adenocarcinoma, meningioma, and renal cell carcinoma.<a class="elsevierStyleCrossRefs" href="#bib1355"><span class="elsevierStyleSup">110–112</span></a> These patients may also develop a gamut of melanocytic proliferations ranging from epithelioid nevi to spitzoid melanocytic proliferations (the so-called ‘BAPomas’) to melanomas (cutaneous and uveal).<a class="elsevierStyleCrossRefs" href="#bib1370"><span class="elsevierStyleSup">113–115</span></a> These tumors are characterized by loss of nuclear BAP1 staining, usually accompanied by of BRAF V600E expression (<a class="elsevierStyleCrossRef" href="#fig0030">Fig. 6</a>).<a class="elsevierStyleCrossRefs" href="#bib1385"><span class="elsevierStyleSup">116–119</span></a> Though BAP1 has traditionally been considered a tumor suppressor, recent studies have reported that BAP1 might play a role in survival of tumor cells.<a class="elsevierStyleCrossRef" href="#bib1405"><span class="elsevierStyleSup">120</span></a></p><elsevierMultimedia ident="fig0030"></elsevierMultimedia></span></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Additional techniques</span><p id="par0090" class="elsevierStylePara elsevierViewall">While most melanocytic lesions can be characterized by microscopic examination of H&E-stained sections and immunostains, some melanocytic proliferations presenting with ambiguous features can be difficult to diagnose accurately. In such cases, molecular studies may provide additional diagnostic information. Though cutaneous melanomas represent a divergent group of diseases, they usually have recurrent, non-random chromosomal abnormalities,<a class="elsevierStyleCrossRefs" href="#bib1410"><span class="elsevierStyleSup">121,122</span></a> and detection of these aberrations may aid in the diagnostic process.<a class="elsevierStyleCrossRef" href="#bib1420"><span class="elsevierStyleSup">123</span></a> The following section will summarize the basic principles and practical application of the various molecular tests for the diagnosis of melanocytic lesions.</p></span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Comparative genomic hybridization</span><p id="par0095" class="elsevierStylePara elsevierViewall">Comparative genomic hybridization (CGH) is a cytogenetic assay that can detect losses and gains of genomic material and map them to specific chromosomes.<a class="elsevierStyleCrossRef" href="#bib1425"><span class="elsevierStyleSup">124</span></a> CGH utilizes differential labeling of genomic DNA extracted from fresh or formalin-fixed tumor and normal tissue (usually peripheral blood leukocytes) with fluorochromes, followed by co-hybridization of equal amounts of each fraction on to metaphase spreads of chromosomes derived from a peripheral blood lymphocytes of a healthy donor (traditional CGH). DNA copy number changes can be determined by comparison of relative signal intensities of the different fluorochromes (<a class="elsevierStyleCrossRef" href="#fig0035">Fig. 7</a>). The main advantage of CGH is the ability to analyze the entire genome simultaneously and objectively, without specific probes. However, the utility of traditional CGH is restricted due to limited resolution of 3–10<span class="elsevierStyleHsp" style=""></span>Mb.<a class="elsevierStyleCrossRef" href="#bib1430"><span class="elsevierStyleSup">125</span></a> This can be overcome by utilizing an array of DNA targets covering the entire genome for hybridization (array CGH).<a class="elsevierStyleCrossRefs" href="#bib1435"><span class="elsevierStyleSup">126,127</span></a></p><elsevierMultimedia ident="fig0035"></elsevierMultimedia><p id="par0100" class="elsevierStylePara elsevierViewall">The potential of CGH in the classification of melanocytic lesions began with the work of Bastian et al., who analyzed 32 primary melanomas.<a class="elsevierStyleCrossRef" href="#bib1445"><span class="elsevierStyleSup">128</span></a> They identified loss of chromosome 9, particularly involving the short arm in majority of the melanomas. In addition, losses of parts of chromosomes 9 and 10 occurred in early lesions, whereas gains of chromosome 7 were late events in melanoma progression. A subsequent study from the same group revealed that chromosomal alterations could be identified in both melanomas and melanocytic nevi, albeit in a lower frequency and particularly in Spitz nevi. While cytogenetic alterations seen in melanomas involved portions of chromosomes, those in nevi typically involved the whole chromosomes or entire arms of the chromosomes.<a class="elsevierStyleCrossRefs" href="#bib1450"><span class="elsevierStyleSup">129,130</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Metastatic melanomas have been shown to have a distinct set of chromosomal abnormalities, compared to primary melanomas.<a class="elsevierStyleCrossRef" href="#bib1460"><span class="elsevierStyleSup">131</span></a> Some studies have revealed that loci of tumor suppressors are frequently deleted while those containing proto-oncogenes may be amplified.<a class="elsevierStyleCrossRefs" href="#bib1465"><span class="elsevierStyleSup">132–134</span></a> Among the amplified genes are <span class="elsevierStyleItalic">BRAF</span> and <span class="elsevierStyleItalic">NRAS</span>,<a class="elsevierStyleCrossRef" href="#bib1475"><span class="elsevierStyleSup">134</span></a> somatic mutations of which have been implicated in early melanomagenesis. Melanomas of various histologic subtypes may be grouped together based on their cytogenetic abnormalities.<a class="elsevierStyleCrossRef" href="#bib1480"><span class="elsevierStyleSup">135</span></a> For example, melanomas that arise in sun-exposed regions may exhibit NRAS and KIT mutations while most superficial spreading melanomas show BRAF mutations.</p><p id="par0110" class="elsevierStylePara elsevierViewall">In addition to aiding in the diagnosis, CGH can also predict the biologic behavior of melanoma to some extent.<a class="elsevierStyleCrossRef" href="#bib1420"><span class="elsevierStyleSup">123</span></a> Gains of 6p were seen exclusively in thicker melanomas, which along with gains at 1q were associated with a poor outcome.<a class="elsevierStyleCrossRef" href="#bib1485"><span class="elsevierStyleSup">136</span></a> The total number of genomic aberrations in a tumor has been correlated with outcome: the higher the number of chromosomal alterations, the worse the prognosis. Some studies have demonstrated that the frequency of homozygous deletions might be a better predictor of metastasis to sentinel lymph nodes and distant sites.<a class="elsevierStyleCrossRef" href="#bib1490"><span class="elsevierStyleSup">137</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">Thus, CGH may be a useful tool that can aid in distinguishing benign melanocytic proliferations from melanomas and, to some extent in predicting the outcome. However, the utility of CGH is limited by requiring a relatively high and “pure” number of tumor cells in the sample. Lesions with admixed tumor infiltrating lymphocytes, other inflammatory cells, and prominent intervening stroma are less frequently successfully studied by CGH. Also, when only a fraction of the cells (<30%) contain the cytogenetic abnormalities, they may evade detection by CGH, thus yielding a false negative result.<a class="elsevierStyleCrossRef" href="#bib1455"><span class="elsevierStyleSup">130</span></a> In addition, the presence of balanced translocations cannot be detected by CGH.</p></span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Fluorescence in situ hybridization</span><p id="par0120" class="elsevierStylePara elsevierViewall">Fluorescence in situ hybridization (FISH) is a cytogenetic assay used to determine the copy number of specific genomic regions.<a class="elsevierStyleCrossRef" href="#bib1495"><span class="elsevierStyleSup">138</span></a> Its application in the diagnosis of melanocytic lesions was realized only recently, after high-throughput use of CGH proved to be challenging for routine clinical use. In this assay, paraffin sections representing the tissue of interest are hybridized with a mixture of differentially labeled fluorescent probes targeting specific cytogenetic loci. The corresponding signals are enumerated per cell as the percentage of lesional cells containing altered number of signals. The advantages of FISH over CGH include the ability to examine the tumor cells specifically for the number of signals and thus, the feasibility for application in lesions with smaller tumor volume. However, since examination of immunofluorescence slides provides less defined morphologic detail than routine sections, dense lymphohistiocytic infiltrate and nevoid morphology of the tumor cells may result in difficult quantification of the FISH signals.</p><p id="par0125" class="elsevierStylePara elsevierViewall">Genomic loci tested by FISH represent regions with the most frequent chromosomal aberrations, and 13 such hotspots were initially identified by analysis of the CGH assays.<a class="elsevierStyleCrossRef" href="#bib1500"><span class="elsevierStyleSup">139</span></a> Of these, combination of four different probes produced the most distinct separation of melanomas from other melanocytic lesions. The initial 4-probe FISH assay utilized probes that target the following loci on chromosomes 6 and 11: 6p25 (RREB1, red), 6q23 (MYB, gold), 11q13 (CCND1, green), and centromere 6 (Cep6, aqua) (<a class="elsevierStyleCrossRef" href="#fig0040">Fig. 8</a>). A lesion was considered to be melanoma if at least one of the following chromosomal abnormalities was present: (i) 3 or more green dots per nucleus (11q13, CCND1) in at least 39% of tumor cells, (ii) 3 or more red dots (6p25, RREB1) in at least 30% of tumor nuclei, (iii) number of RREB1 signals (red dots) greater than the number of centromere 6 signals (aqua dots) in more than 55% of tumor nuclei and (iv) at least 41% of tumor cells with fewer number of MYB signals (gold dots), compared to centromere 6 signals (aqua dots). Using these criteria, nevi could be distinguished from melanomas with high sensitivity (90%) and specificity (95%). Of these, gain of 6p25 was found to have the highest sensitivity for this distinction.<a class="elsevierStyleCrossRefs" href="#bib1505"><span class="elsevierStyleSup">140,141</span></a></p><elsevierMultimedia ident="fig0040"></elsevierMultimedia><p id="par0130" class="elsevierStylePara elsevierViewall">The applicability of FISH with the 4-probe method has been examined in various settings including pigmented melanocytic lesions with blue nevus like morphology<a class="elsevierStyleCrossRefs" href="#bib1515"><span class="elsevierStyleSup">142,143</span></a>; lesions with desmoplastic response<a class="elsevierStyleCrossRef" href="#bib1525"><span class="elsevierStyleSup">144</span></a>; lesions with nevoid melanocytes<a class="elsevierStyleCrossRefs" href="#bib1530"><span class="elsevierStyleSup">145,146</span></a>; conjunctival melanocytic lesions<a class="elsevierStyleCrossRef" href="#bib1540"><span class="elsevierStyleSup">147</span></a> and even intranodal melanocytic deposits<a class="elsevierStyleCrossRef" href="#bib1545"><span class="elsevierStyleSup">148</span></a>, as well as in distinguishing melanoma cells from associated nevocytes<a class="elsevierStyleCrossRef" href="#bib1535"><span class="elsevierStyleSup">146</span></a>. In addition, it is unknown how useful FISH is in ambiguous melanocytic lesions since most studies were done in histologically obvious nevi or melanoma and the presence of cytogenetic alterations did not always correlate with the clinical outcome.<a class="elsevierStyleCrossRefs" href="#bib1500"><span class="elsevierStyleSup">139,149–152</span></a> Furthermore, the presence of tetraploidy and polyploidy (common in Spitz and other melanocytic nevi) may yield false positive results.<a class="elsevierStyleCrossRefs" href="#bib1560"><span class="elsevierStyleSup">151,153–155</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">Additional genomic loci initially identified by CGH were examined to address the lack of sensitivity of conventional 4-probe FISH assay with respect ambiguous melanocytic lesions and in identifying polyploidy.<a class="elsevierStyleCrossRef" href="#bib1585"><span class="elsevierStyleSup">156</span></a> Based on this, the current FISH panel includes probes against 6p25 (RREB1, red), 9p21 (CDKN2A, gold), 11q13 (CCND1, green), 8q24 (MYC, aqua) and centromere 9 (Cep9, green). The presence of at least 30% of tumor cells with gains of RREB1 (red), CCND1 (green) or MYC (aqua) with or without homozygous deletion of CDKN2A (gold) is considered to be a positive result. Use of this probe set has increased the sensitivity from 75% to 94% for the diagnosis of melanoma, in addition to eliminating most false positive results due to tetraploidy.<a class="elsevierStyleCrossRef" href="#bib1590"><span class="elsevierStyleSup">157</span></a> Though this is a significant improvement from the initial panel, FISH assay should be used only to supplement the findings of a thorough histopathologic examination and the results from a FISH study should not influence the management of the patient.<a class="elsevierStyleCrossRef" href="#bib1565"><span class="elsevierStyleSup">152</span></a></p><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Imaging mass spectrometry</span><p id="par0140" class="elsevierStylePara elsevierViewall">Mass spectrometry (MS) is a technique that utilizes molecule specific mass to charge (<span class="elsevierStyleItalic">m</span>/<span class="elsevierStyleItalic">z</span>) ratios to identify and quantify substances from various sources.<a class="elsevierStyleCrossRef" href="#bib1510"><span class="elsevierStyleSup">141</span></a> MS involves generation of gas phase ions from the substance of interest, and then subject them to progressive fragmentation. The ions are separated based on their mass and charge and their amplitude of detection as ‘peaks’ would be directly proportional to their relative concentration in the parent substance. Each molecule has a specific <span class="elsevierStyleItalic">m</span>/<span class="elsevierStyleItalic">z</span> ratio, which will allow identification of the molecular composition of the parent substance.</p><p id="par0145" class="elsevierStylePara elsevierViewall">Imaging mass spectrometry (IMS) is a process where the MS analyses are performed directly on tissue sections. Therefore, the analysis can be restricted to specific regions of the sections, and thus, target only cells of interest with minimal contamination from the adjacent tissues.<a class="elsevierStyleCrossRefs" href="#bib1320"><span class="elsevierStyleSup">103,158</span></a> In contrast to routine immunohistochemical studies and other ancillary tests used in pathology, using IMS, the distribution and abundance of all proteins and peptides can be analyzed simultaneously. In situ imaging of proteins provides an unbiased view of molecular composition of tissues and has been used mostly in the research setting so far.<a class="elsevierStyleCrossRef" href="#bib1600"><span class="elsevierStyleSup">159</span></a></p><p id="par0150" class="elsevierStylePara elsevierViewall">In an attempt to facilitate accurate diagnosis of spitzoid lesions, Lazova and colleagues analyzed 114 cases,<a class="elsevierStyleCrossRef" href="#bib1605"><span class="elsevierStyleSup">160</span></a> with 51 as the training set, and a validation set of 63 cases. Two serial sections of formalin fixed paraffin tissues were cut on to a glass side for H&E staining and on to a conductive glass slide for IMS. After marking areas of interest on the H&E slide, including dense areas of tumor devoid of other cells such as stroma or lymphocytes, the corresponding areas on the conductive slide were analyzed by IMS. Of the multiple models studied by the researchers, 5 peaks corresponding to tumor and 12 peaks corresponding to tumor microenvironment were found to provide the most discrimination between Spitz nevi (SN) and spitzoid melanoma (SMM). Tumor-associated peptides could distinguish the spitzoid lesion with a sensitivity of 97% and specificity of 90%, whereas the sensitivity and specificities of tumor microenvironment-associated peptides were 64% and 90%, respectively. Of the five differentially expressed tumor-associated peptides, the authors were able to identify actin and vimentin. Though IMS is at an early stage, it has shown promise in distinguishing between melanoma and congenital nevi.<a class="elsevierStyleCrossRef" href="#bib1610"><span class="elsevierStyleSup">161</span></a></p></span></span><span id="sec0110" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Conclusion</span><p id="par0155" class="elsevierStylePara elsevierViewall">Melanoma continues to be a deadly disease and accurate diagnosis is critical for appropriate treatment of the patient. The various ancillary tests mentioned in this review serve as supplements to thorough histologic examination. In addition, they can also provide valid prognostic information and identify patients that may benefit from targeted therapy.</p></span><span id="sec0115" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Conflict of interest</span><p id="par0160" class="elsevierStylePara elsevierViewall">The authors declare no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:15 [ 0 => array:3 [ "identificador" => "xres782855" "titulo" => "Graphical abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:3 [ "identificador" => "xres782854" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 2 => array:2 [ "identificador" => "xpalclavsec781823" "titulo" => "Keywords" ] 3 => array:3 [ "identificador" => "xres782856" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0015" ] ] ] 4 => array:2 [ "identificador" => "xpalclavsec781824" "titulo" => "Palabras clave" ] 5 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 6 => array:2 [ "identificador" => "sec0010" "titulo" => "Immunohistochemistry" ] 7 => array:3 [ "identificador" => "sec0015" "titulo" => "Markers of melanocytic differentiation" "secciones" => array:8 [ 0 => array:2 [ "identificador" => "sec0020" "titulo" => "S100B" ] 1 => array:2 [ "identificador" => "sec0025" "titulo" => "HMB45" ] 2 => array:2 [ "identificador" => "sec0030" "titulo" => "MART1" ] 3 => array:2 [ "identificador" => "sec0035" "titulo" => "Tyrosinase" ] 4 => array:2 [ "identificador" => "sec0040" "titulo" => "MITF" ] 5 => array:2 [ "identificador" => "sec0045" "titulo" => "SOX10" ] 6 => array:2 [ "identificador" => "sec0050" "titulo" => "p75NGFR" ] 7 => array:2 [ "identificador" => "sec0055" "titulo" => "Melanocytic marker cocktails" ] ] ] 8 => array:3 [ "identificador" => "sec0060" "titulo" => "Prognostic markers of melanoma" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0065" "titulo" => "Ki67" ] 1 => array:2 [ "identificador" => "sec0070" "titulo" => "pHH3" ] 2 => array:2 [ "identificador" => "sec0075" "titulo" => "D2-40" ] 3 => array:2 [ "identificador" => "sec0080" "titulo" => "BRAFV600E" ] 4 => array:2 [ "identificador" => "sec0085" "titulo" => "BAP1" ] ] ] 9 => array:2 [ "identificador" => "sec0090" "titulo" => "Additional techniques" ] 10 => array:2 [ "identificador" => "sec0095" "titulo" => "Comparative genomic hybridization" ] 11 => array:3 [ "identificador" => "sec0100" "titulo" => "Fluorescence in situ hybridization" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0105" "titulo" => "Imaging mass spectrometry" ] ] ] 12 => array:2 [ "identificador" => "sec0110" "titulo" => "Conclusion" ] 13 => array:2 [ "identificador" => "sec0115" "titulo" => "Conflict of interest" ] 14 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2016-01-25" "fechaAceptado" => "2016-05-09" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec781823" "palabras" => array:6 [ 0 => "Melanoma" 1 => "Diagnosis" 2 => "Immunohistochemistry" 3 => "Comparative genomic hybridization" 4 => "Fluorescence in situ hybridization" 5 => "Mass spectrometry" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec781824" "palabras" => array:6 [ 0 => "Melanoma" 1 => "Diagnóstico" 2 => "Inmunohistoquímica" 3 => "Hibridación genómica comparativa" 4 => "Hibridación <span class="elsevierStyleItalic">in situ</span> con fluorescencia" 5 => "Espectometría de masas" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Melanoma remains one of the most aggressive forms of cutaneous malignancies. While its diagnosis based on histologic parameters is usually straight forward in most cases, distinguishing a melanoma from a melanocytic nevus can be challenging in some instances, especially when there are overlapping clinical and histopathologic features. Occasionally, melanomas can histologically mimic other tumors and even demonstration of melanocytic origin can be challenging. Thus, several ancillary tests may be employed to arrive at the correct diagnosis. The objective of this review is to summarize these tests, including the well-established and commonly used ones such as immunohistochemistry, with specific emphasis on emerging techniques such as comparative genomic hybridization, fluorescence in situ hybridization and imaging mass spectrometry.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0015" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Los melanomas continúan siendo unas de las neoplasias cutáneas más agresivas. Si bien su diagnóstico por medio de parámetros histológicos suele ser sencillo en la mayoría de los casos, la distinción entre un melanoma y un nevo melanocítico puede suponer un reto en ocasiones, sobre todo cuando las características histopatológicas y clínicas se solapan. A veces los melanomas pueden imitar histológicamente a otros tumores, e incluso demostrar el origen melanocítico resulta complicado. Por tanto, se deben realizar varias pruebas complementarias para alcanzar el diagnóstico correcto. El objetivo de la presente revisión es resumir dichas pruebas, entre las que se incluyen algunas de uso habitual como la inmunohistoquímica, enfatizando de manera específica en las técnicas emergentes como la hibridación genómica comparativa, la hibridación in situ con fluorescencia y la espectrometría de masas.</p></span>" ] ] "multimedia" => array:9 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 597 "Ancho" => 1600 "Tamanyo" => 334330 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Immunohistochemical study for microphthalmia-associated transcription factor (MITF). (A) Invasive melanoma diffusely positive nuclear labeling in melanocytic lesions with epithelioid melanocytes (magnification 200×). (B) Melanoma in situ, with contiguous proliferation and suprabasal spread of atypical melanocytes (magnification 200×).</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 597 "Ancho" => 1600 "Tamanyo" => 263720 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Immunohistochemical study for SOX10. (A) Melanoma in situ, with contiguous proliferation and suprabasal spread of atypical melanocytes (magnification 200×). (B) Desmoplastic melanoma with diffusely positive nuclear expression (magnification × 100).</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 746 "Ancho" => 990 "Tamanyo" => 331840 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Immunohistochemical study using melanocytic cocktail (HMB45 and anti-tyrosinase) highlights intraepidermal and dermal components of this superficial spreading melanoma (magnification × 100).</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 2275 "Ancho" => 990 "Tamanyo" => 790123 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Immunohistochemical studies for prognostic factors. (A) Mart-1/Ki67 cocktail highlights the melanoma cells (red, cytoplasmic) with increased nuclear positivity for Ki67 (brown, nuclear) (magnification 200×). (B) Mart-1/PHH3 cocktail highlights a mitotic figure (brown) in a melanoma (red, cytoplasmic) (magnification 200×). (C) MITF/D2-40 reveals the presence of lymphovascular (red) space invasion by melanoma cells (brown, nuclear) (magnification × 100).</p>" ] ] 4 => array:7 [ "identificador" => "fig0025" "etiqueta" => "Figure 5" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr5.jpeg" "Alto" => 597 "Ancho" => 1600 "Tamanyo" => 353270 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Immunohistochemical study for BRAF V600E. (A) Diffuse cytoplasmic positivity, indicating the presence of BRAF V600E mutation in the majority of cells (magnification 200×). (B) Negative stain, indicating wild type <span class="elsevierStyleItalic">BRAF</span> status (magnification × 200).</p>" ] ] 5 => array:7 [ "identificador" => "fig0030" "etiqueta" => "Figure 6" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr6.jpeg" "Alto" => 1205 "Ancho" => 1600 "Tamanyo" => 1110055 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Immunohistochemical studies for BAP1 and BRAF in a ‘BAPoma’. (A) Hematoxylin and eosin stained section of a dome-shaped BAPoma with dense proliferation of epithelioid melanocytes within the dermis (magnification 40×). (B) Typical nevus cells are also present at the peripheral of epithelioid proliferation (right side, magnification 100×). (C) Diffuse loss of nuclear BAP1 in most of the melanocytes; arrowhead indicates single positive cell. Of note, the background cytoplasmic reaction should not be interpreted as positive (magnification 200×). (D) These cells are diffusely positive for BRAF V600E protein (magnification × 200).</p>" ] ] 6 => array:7 [ "identificador" => "fig0035" "etiqueta" => "Figure 7" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr7.jpeg" "Alto" => 2257 "Ancho" => 1648 "Tamanyo" => 274607 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Schematic representing major steps in CGH. Left side demonstrates critical steps of a traditional CGH, while right side includes the commonly used array CGH.</p>" ] ] 7 => array:7 [ "identificador" => "fig0040" "etiqueta" => "Figure 8" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr8.jpeg" "Alto" => 893 "Ancho" => 1501 "Tamanyo" => 144752 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Four-probe FISH assay. (A) Normal cell with two signals each of 6p25 (RREB1, red), 6q23 (MYB, gold), 11q13 (CCND1, green), and centromere 6 (Cep6, aqua). (B) Melanoma cell with an abnormal FISH result with multiple RREB1 (6 red dots) and CCND1 signals (7 green dots), indicating gains at 6p25 and 11q13, respectively.</p>" ] ] 8 => array:5 [ "identificador" => "fig0045" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 566 "Ancho" => 1333 "Tamanyo" => 197735 ] ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:161 [ 0 => array:3 [ "identificador" => "bib0810" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Protocol for the examination of specimens from patients with melanoma of the skin" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1043/1543-2165-133.10.1560" "Revista" => array:6 [ …6] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0815" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Divergent differentiation in malignant melanomas: a review" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2559.2007.02823.x" "Revista" => array:6 [ …6] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0820" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Morphological and immunophenotypic variations in malignant melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0825" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Unusual variants of malignant melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/modpathol.3800516" "Revista" => array:7 [ …7] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0830" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemical characteristics of melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.2007.00891.x" "Revista" => array:6 [ …6] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0835" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemistry as an important tool in biomarkers detection and clinical practice" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0840" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Beyond hematoxylin and eosin – the role of immunohistochemistry in surgical pathology" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0845" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunological properties of an antibody containing a fluorescent group" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0850" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0855" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Re-evaluation of melanin bleaching using warm diluted hydrogen peroxide for histopathological analysis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1440-1827.2011.02667.x" "Revista" => array:6 [ …6] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0860" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of immunohistochemistry in melanocytic lesions" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.2008.01130.x" "Revista" => array:7 [ …7] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0865" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemistry of melanocytic proliferations" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1043/2009-0717-RAR.1" "Revista" => array:6 [ …6] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0870" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metastatic melanoma mimicking solitary fibrous tumor: report of two cases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00428-014-1542-5" "Revista" => array:6 [ …6] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0875" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunophenotypic heterogeneity of primary sinonasal melanoma with aberrant expression of neuroendocrine markers and calponin" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/PAI.0b013e3181ee8dcb" "Revista" => array:6 [ …6] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0880" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/modpathol.2015.62" "Revista" => array:6 [ …6] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0885" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.humpath.2013.02.007" "Revista" => array:6 [ …6] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0890" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic and prognostic biomarkers in melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0895" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "S100 protein is present in cultured human malignant melanomas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0900" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0905" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0910" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "S100 protein: a marker for human malignant melanomas?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0915" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "S100 proteins in cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nrc3893" "Revista" => array:6 [ …6] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0920" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/CMR.0b013e32831993cc" "Revista" => array:6 [ …6] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0925" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0930" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.2007.00953.x" "Revista" => array:6 [ …6] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0935" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Loss of S100 antigenicity in metastatic melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.humpath.2005.07.010" "Revista" => array:6 [ …6] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0940" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2009.11.688" "Revista" => array:6 [ …6] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0945" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular characterization of the melanocyte lineage-specific antigen gp100" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0950" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0955" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Analysis of HMB-45 immunoreactivity in common and cellular blue nevi" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0960" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0965" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of MelanA/MART-1 and HMB45 labeling in desmoplastic melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/modpathol.2014.59" "Revista" => array:6 [ …6] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0970" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The use of immunocytochemical study in the cytologic diagnosis of melanoma: evaluation of three antibodies" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/dc.21791" "Revista" => array:6 [ …6] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0975" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0980" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1074/jbc.M413692200" "Revista" => array:6 [ …6] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0985" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0990" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Melan-A, a new melanocytic differentiation marker" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0995" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A103: an anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib1000" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib1005" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib1010" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Melan-a-positive pseudomelanocytic nests: a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e31819d3769" "Revista" => array:6 [ …6] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib1015" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunostaining for MART-1 in the interpretation of problematic intra-epidermal pigmented lesions" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.2006.00673.x" "Revista" => array:6 [ …6] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib1020" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib1025" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib1030" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib1035" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib1040" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0344-0338(00)80072-2" "Revista" => array:6 [ …6] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib1045" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1043/0003-9985(2002)126<0816:TEIMMD>2.0.CO;2" "Revista" => array:6 [ …6] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib1050" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular cloning of cDNA encoding a novel microphthalmia-associated transcription factor isoform with a distinct amino-terminus" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib1055" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MITF: master regulator of melanocyte development and melanoma oncogene" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.molmed.2006.07.008" "Revista" => array:6 [ …6] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib1060" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib1065" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib1070" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib1075" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib1080" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncy.21458" "Revista" => array:6 [ …6] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib1085" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e31825666c3" "Revista" => array:6 [ …6] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib1090" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e318291485c" "Revista" => array:6 [ …6] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib1095" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1074/jbc.M003816200" "Revista" => array:6 [ …6] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib1100" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.onc.1206442" "Revista" => array:6 [ …6] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib1105" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sox10-a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/PAS.0000000000000398" "Revista" => array:6 [ …6] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib1110" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "SOX10 expression in malignant melanoma, carcinoma, and normal tissues" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/PAI.0b013e318279bc0a" "Revista" => array:6 [ …6] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib1115" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5858/arpa.2014-0077-OA" "Revista" => array:6 [ …6] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib1120" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e31827a0b98" "Revista" => array:6 [ …6] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib1125" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "CD271 mediates stem cells to early progeny transition in human epidermis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jid.2014.454" "Revista" => array:6 [ …6] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib1130" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib1135" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e318225b596" "Revista" => array:6 [ …6] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib1140" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.2011.01718.x" "Revista" => array:6 [ …6] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib1145" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "NGFR (p75) expression in cutaneous scars; further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e3181dfcb9f" "Revista" => array:6 [ …6] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib1150" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/hupa.2001.27602" "Revista" => array:6 [ …6] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib1155" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib1160" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib1165" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib1170" "etiqueta" => "73" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib1175" "etiqueta" => "74" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e3181624054" "Revista" => array:6 [ …6] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib1180" "etiqueta" => "75" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib1185" "etiqueta" => "76" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib1190" "etiqueta" => "77" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1067/mjd.2001.110067" "Revista" => array:6 [ …6] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib1195" "etiqueta" => "78" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1471-2407-10-140" "Revista" => array:5 [ …5] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib1200" "etiqueta" => "79" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Suprabasal spread of melanocytes in dysplastic nevi and melanoma in situ: Ki-67-labeling rate of junctional melanocytes and suprabasal cells may be a helpful clue to the diagnosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/PAS.0000000000000224" "Revista" => array:6 [ …6] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib1205" "etiqueta" => "80" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/jco.2001.19.16.3635" "Revista" => array:6 [ …6] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib1210" "etiqueta" => "81" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib1215" "etiqueta" => "82" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "H3 phosphorylation: dual role in mitosis and interphase" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1139/O09-053" "Revista" => array:6 [ …6] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib1220" "etiqueta" => "83" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Emerging clinical applications of selected biomarkers in melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2147/CCID.S49578" "Revista" => array:6 [ …6] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib1225" "etiqueta" => "84" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/modpathol.2013.59" "Revista" => array:6 [ …6] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib1230" "etiqueta" => "85" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/modpathol.2012.188" "Revista" => array:6 [ …6] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib1235" "etiqueta" => "86" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e3181cf7cc1" "Revista" => array:6 [ …6] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib1240" "etiqueta" => "87" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/DAD.0b013e31823135a3" "Revista" => array:6 [ …6] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib1245" "etiqueta" => "88" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.2011.01858.x" "Revista" => array:6 [ …6] ] ] ] ] ] 88 => array:3 [ "identificador" => "bib1250" "etiqueta" => "89" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/modpathol.3880543" "Revista" => array:6 [ …6] ] ] ] ] ] 89 => array:3 [ "identificador" => "bib1255" "etiqueta" => "90" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2559.2005.02098.x" "Revista" => array:6 [ …6] ] ] ] ] ] 90 => array:3 [ "identificador" => "bib1260" "etiqueta" => "91" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archderm.144.4.462" "Revista" => array:6 [ …6] ] ] ] ] ] 91 => array:3 [ "identificador" => "bib1265" "etiqueta" => "92" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.2008.01242.x" "Revista" => array:6 [ …6] ] ] ] ] ] 92 => array:3 [ "identificador" => "bib1270" "etiqueta" => "93" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0560.2008.01166.x" "Revista" => array:6 [ …6] ] ] ] ] ] 93 => array:3 [ "identificador" => "bib1275" "etiqueta" => "94" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lymphovascular invasion: assessment and prognostic impact in melanoma and breast cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.14670/HH-11-615" "Revista" => array:6 [ …6] ] ] ] ] ] 94 => array:3 [ "identificador" => "bib1280" "etiqueta" => "95" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2009.04.026" "Revista" => array:6 [ …6] ] ] ] ] ] 95 => array:3 [ "identificador" => "bib1285" "etiqueta" => "96" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "[Epub ahead of print]. doi:10.1097/DAD.0000000000000453" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic significance of lymphovascular invasion detected by double immunostaining for D2-40 and MITF1 in patients with cutaneous melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ …2] ] ] ] ] ] 96 => array:3 [ "identificador" => "bib1290" "etiqueta" => "97" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mutations of the BRAF gene in human cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nature00766" "Revista" => array:6 [ …6] ] ] ] ] ] 97 => array:3 [ "identificador" => "bib1295" "etiqueta" => "98" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of BRAF V600 mutation in melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1479-5876-10-85" "Revista" => array:5 [ …5] ] ] ] ] ] 98 => array:3 [ "identificador" => "bib1300" "etiqueta" => "99" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vemurafenib for the treatment of BRAF mutant metastatic melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2217/fon.14.252" "Revista" => array:6 [ …6] ] ] ] ] ] 99 => array:3 [ "identificador" => "bib1305" "etiqueta" => "100" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/PAS.0b013e31826485c0" "Revista" => array:6 [ …6] ] ] ] ] ] 100 => array:3 [ "identificador" => "bib1310" "etiqueta" => "101" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00401-011-0841-z" "Revista" => array:6 [ …6] ] ] ] ] ] 101 => array:3 [ "identificador" => "bib1315" "etiqueta" => "102" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.humpath.2013.06.018" "Revista" => array:6 [ …6] ] ] ] ] ] 102 => array:3 [ "identificador" => "bib1320" "etiqueta" => "103" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Utility of BRAF V600E immunohistochemical expression pattern as a surrogate of BRAF mutation status in 154 patients with advanced melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.humpath.2015.04.012" "Revista" => array:6 [ …6] ] ] ] ] ] 103 => array:3 [ "identificador" => "bib1325" "etiqueta" => "104" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra- and inter-tumoral homogeneity of BRAF(V600E) mutations in melanoma tumors" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jid.2015.229" "Revista" => array:6 [ …6] ] ] ] ] ] 104 => array:3 [ "identificador" => "bib1330" "etiqueta" => "105" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intra- and inter-tumor heterogeneity of BRAF(V600E)mutations in primary and metastatic melanoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0029336" "Revista" => array:5 [ …5] ] ] ] ] ] 105 => array:3 [ "identificador" => "bib1335" "etiqueta" => "106" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "[in press]. doi:10.1111/cup.12714" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ …2] ] ] ] ] ] 106 => array:3 [ "identificador" => "bib1340" "etiqueta" => "107" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/PAI.0000000000000013" "Revista" => array:6 [ …6] ] ] ] ] ] 107 => array:3 [ "identificador" => "bib1345" "etiqueta" => "108" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "BAP1, a candidate tumor suppressor protein that interacts with BRCA1" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 108 => array:3 [ "identificador" => "bib1350" "etiqueta" => "109" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/carcin/bgu227" "Revista" => array:6 [ …6] ] ] ] ] ] 109 => array:3 [ "identificador" => "bib1355" "etiqueta" => "110" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Germline BAP1 mutations predispose to malignant mesothelioma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ng.912" "Revista" => array:6 [ …6] ] ] ] ] ] 110 => array:3 [ "identificador" => "bib1360" "etiqueta" => "111" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tumours associated with BAP1 mutations" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/PAT.0b013e32835d0efb" "Revista" => array:6 [ …6] ] ] ] ] ] 111 => array:3 [ "identificador" => "bib1365" "etiqueta" => "112" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/jmedgenet-2011-100156" "Revista" => array:6 [ …6] ] ] ] ] ] 112 => array:3 [ "identificador" => "bib1370" "etiqueta" => "113" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Germline mutations in BAP1 predispose to melanocytic tumors" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ng.910" "Revista" => array:6 [ …6] ] ] ] ] ] 113 => array:3 [ "identificador" => "bib1375" "etiqueta" => "114" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/cup.12493" "Revista" => array:6 [ …6] ] ] ] ] ] 114 => array:3 [ "identificador" => "bib1380" "etiqueta" => "115" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 115 => array:3 [ "identificador" => "bib1385" "etiqueta" => "116" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 116 => array:3 [ "identificador" => "bib1390" "etiqueta" => "117" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 117 => array:3 [ "identificador" => "bib1395" "etiqueta" => "118" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 118 => array:3 [ "identificador" => "bib1400" "etiqueta" => "119" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 119 => array:3 [ "identificador" => "bib1405" "etiqueta" => "120" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 120 => array:3 [ "identificador" => "bib1410" "etiqueta" => "121" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 121 => array:3 [ "identificador" => "bib1415" "etiqueta" => "122" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 122 => array:3 [ "identificador" => "bib1420" "etiqueta" => "123" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 123 => array:3 [ "identificador" => "bib1425" "etiqueta" => "124" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 124 => array:3 [ "identificador" => "bib1430" "etiqueta" => "125" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 125 => array:3 [ "identificador" => "bib1435" "etiqueta" => "126" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 126 => array:3 [ "identificador" => "bib1440" "etiqueta" => "127" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 127 => array:3 [ "identificador" => "bib1445" "etiqueta" => "128" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 128 => array:3 [ "identificador" => "bib1450" "etiqueta" => "129" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 129 => array:3 [ "identificador" => "bib1455" "etiqueta" => "130" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 130 => array:3 [ "identificador" => "bib1460" "etiqueta" => "131" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:1 [ …1] ] ] ] ] 131 => array:3 [ "identificador" => "bib1465" "etiqueta" => "132" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 132 => array:3 [ "identificador" => "bib1470" "etiqueta" => "133" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 133 => array:3 [ "identificador" => "bib1475" "etiqueta" => "134" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 134 => array:3 [ "identificador" => "bib1480" "etiqueta" => "135" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 135 => array:3 [ "identificador" => "bib1485" "etiqueta" => "136" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 136 => array:3 [ "identificador" => "bib1490" "etiqueta" => "137" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 137 => array:3 [ "identificador" => "bib1495" "etiqueta" => "138" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 138 => array:3 [ "identificador" => "bib1500" "etiqueta" => "139" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 139 => array:3 [ "identificador" => "bib1505" "etiqueta" => "140" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 140 => array:3 [ "identificador" => "bib1510" "etiqueta" => "141" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 141 => array:3 [ "identificador" => "bib1515" "etiqueta" => "142" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 142 => array:3 [ "identificador" => "bib1520" "etiqueta" => "143" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 143 => array:3 [ "identificador" => "bib1525" "etiqueta" => "144" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 144 => array:3 [ "identificador" => "bib1530" "etiqueta" => "145" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 145 => array:3 [ "identificador" => "bib1535" "etiqueta" => "146" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 146 => array:3 [ "identificador" => "bib1540" "etiqueta" => "147" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 147 => array:3 [ "identificador" => "bib1545" "etiqueta" => "148" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 148 => array:3 [ "identificador" => "bib1550" "etiqueta" => "149" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 149 => array:3 [ "identificador" => "bib1555" "etiqueta" => "150" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 150 => array:3 [ "identificador" => "bib1560" "etiqueta" => "151" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 151 => array:3 [ "identificador" => "bib1565" "etiqueta" => "152" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 152 => array:3 [ "identificador" => "bib1570" "etiqueta" => "153" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 153 => array:3 [ "identificador" => "bib1575" "etiqueta" => "154" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 154 => array:3 [ "identificador" => "bib1580" "etiqueta" => "155" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 155 => array:3 [ "identificador" => "bib1585" "etiqueta" => "156" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 156 => array:3 [ "identificador" => "bib1590" "etiqueta" => "157" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 157 => array:3 [ "identificador" => "bib1595" "etiqueta" => "158" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 158 => array:3 [ "identificador" => "bib1600" "etiqueta" => "159" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 159 => array:3 [ "identificador" => "bib1605" "etiqueta" => "160" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] 160 => array:3 [ "identificador" => "bib1610" "etiqueta" => "161" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ …2] ] "host" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/0000010800000001/v1_201612270122/S0001731016301545/v1_201612270122/en/main.assets" "Apartado" => array:4 [ "identificador" => "6158" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Revisiones" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/0000010800000001/v1_201612270122/S0001731016301545/v1_201612270122/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731016301545?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 13 | 8 | 21 |
| 2024 Octubre | 75 | 32 | 107 |
| 2024 Septiembre | 93 | 23 | 116 |
| 2024 Agosto | 113 | 59 | 172 |
| 2024 Julio | 89 | 37 | 126 |
| 2024 Junio | 118 | 71 | 189 |
| 2024 Mayo | 121 | 49 | 170 |
| 2024 Abril | 124 | 62 | 186 |
| 2024 Marzo | 112 | 27 | 139 |
| 2024 Febrero | 91 | 31 | 122 |
| 2024 Enero | 57 | 35 | 92 |
| 2023 Diciembre | 100 | 37 | 137 |
| 2023 Noviembre | 110 | 37 | 147 |
| 2023 Octubre | 88 | 46 | 134 |
| 2023 Septiembre | 82 | 40 | 122 |
| 2023 Agosto | 90 | 21 | 111 |
| 2023 Julio | 127 | 34 | 161 |
| 2023 Junio | 77 | 44 | 121 |
| 2023 Mayo | 112 | 23 | 135 |
| 2023 Abril | 137 | 30 | 167 |
| 2023 Marzo | 160 | 55 | 215 |
| 2023 Febrero | 189 | 44 | 233 |
| 2023 Enero | 140 | 34 | 174 |
| 2022 Diciembre | 168 | 56 | 224 |
| 2022 Noviembre | 192 | 46 | 238 |
| 2022 Octubre | 184 | 54 | 238 |
| 2022 Septiembre | 141 | 69 | 210 |
| 2022 Agosto | 149 | 63 | 212 |
| 2022 Julio | 120 | 50 | 170 |
| 2022 Junio | 178 | 39 | 217 |
| 2022 Mayo | 226 | 62 | 288 |
| 2022 Abril | 130 | 73 | 203 |
| 2022 Marzo | 134 | 75 | 209 |
| 2022 Febrero | 109 | 61 | 170 |
| 2022 Enero | 124 | 65 | 189 |
| 2021 Diciembre | 72 | 74 | 146 |
| 2021 Noviembre | 112 | 72 | 184 |
| 2021 Octubre | 117 | 95 | 212 |
| 2021 Septiembre | 114 | 56 | 170 |
| 2021 Agosto | 113 | 59 | 172 |
| 2021 Julio | 72 | 41 | 113 |
| 2021 Junio | 107 | 49 | 156 |
| 2021 Mayo | 146 | 55 | 201 |
| 2021 Abril | 366 | 134 | 500 |
| 2021 Marzo | 177 | 62 | 239 |
| 2021 Febrero | 122 | 36 | 158 |
| 2021 Enero | 107 | 38 | 145 |
| 2020 Diciembre | 80 | 37 | 117 |
| 2020 Noviembre | 52 | 28 | 80 |
| 2020 Octubre | 50 | 23 | 73 |
| 2020 Septiembre | 57 | 19 | 76 |
| 2020 Agosto | 51 | 28 | 79 |
| 2020 Julio | 60 | 30 | 90 |
| 2020 Junio | 53 | 45 | 98 |
| 2020 Mayo | 36 | 30 | 66 |
| 2020 Abril | 35 | 31 | 66 |
| 2020 Marzo | 26 | 19 | 45 |
| 2020 Febrero | 5 | 0 | 5 |
| 2019 Diciembre | 4 | 0 | 4 |
| 2019 Noviembre | 1 | 1 | 2 |
| 2019 Septiembre | 6 | 0 | 6 |
| 2019 Julio | 1 | 2 | 3 |
| 2019 Mayo | 2 | 1 | 3 |
| 2019 Abril | 1 | 5 | 6 |
| 2019 Marzo | 1 | 2 | 3 |
| 2019 Febrero | 2 | 0 | 2 |
| 2018 Diciembre | 6 | 0 | 6 |
| 2018 Noviembre | 3 | 2 | 5 |
| 2018 Octubre | 3 | 0 | 3 |
| 2018 Septiembre | 3 | 0 | 3 |
| 2018 Julio | 1 | 0 | 1 |
| 2018 Junio | 0 | 1 | 1 |
| 2018 Mayo | 2 | 1 | 3 |
| 2018 Abril | 2 | 0 | 2 |
| 2018 Marzo | 1 | 1 | 2 |
| 2018 Febrero | 30 | 3 | 33 |
| 2018 Enero | 71 | 20 | 91 |
| 2017 Diciembre | 42 | 8 | 50 |
| 2017 Noviembre | 33 | 10 | 43 |
| 2017 Octubre | 20 | 11 | 31 |
| 2017 Septiembre | 18 | 21 | 39 |
| 2017 Agosto | 21 | 20 | 41 |
| 2017 Julio | 23 | 11 | 34 |
| 2017 Junio | 19 | 21 | 40 |
| 2017 Mayo | 44 | 22 | 66 |
| 2017 Abril | 26 | 37 | 63 |
| 2017 Marzo | 27 | 44 | 71 |
| 2017 Febrero | 22 | 70 | 92 |
| 2017 Enero | 48 | 103 | 151 |
| 2016 Diciembre | 8 | 36 | 44 |
| 2016 Noviembre | 0 | 22 | 22 |
| 2016 Octubre | 0 | 21 | 21 |
| 2016 Julio | 4 | 14 | 18 |
Mostrar todo
